Correlation Between Bright Minds and Dermata Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bright Minds and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bright Minds and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bright Minds Biosciences and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on Bright Minds and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bright Minds with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bright Minds and Dermata Therapeutics.

Diversification Opportunities for Bright Minds and Dermata Therapeutics

0.02

Correlation Coefficient

Bright Minds  Dermata Therapeutics

Significant diversification

The 3 months correlation between Bright and Dermata is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Bright Minds Biosciences and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Bright Minds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bright Minds Biosciences are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Bright Minds i.e., Bright Minds and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Bright Minds and Dermata Therapeutics

Given the investment horizon of 90 days Bright Minds is expected to generate 49.6 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, Bright Minds Biosciences is 4.67 times less risky than Dermata Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  1.07  in Dermata Therapeutics Warrant on December 29, 2024 and sell it today you would earn a total of  1.73  from holding Dermata Therapeutics Warrant or generate 161.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	78.69%
Values	Daily Returns

Bright Minds Biosciences  vs.  Dermata Therapeutics Warrant

Bright Minds Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Bright Minds is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Dermata Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics Warrant are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bright Minds and Dermata Therapeutics

The main advantage of trading using opposite Bright Minds and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bright Minds position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.

The idea behind Bright Minds Biosciences and Dermata Therapeutics Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.